← Back to all trials
Active Not Recruiting
NCT04433234
Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy
Sex: Male
Ages: 5 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 8
Sponsor: Daiichi Sankyo Co., Ltd.
Location: National Center of Neurology and Psychiatry Tokyo Kodaira-Shi
Summary
This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
Eligibility Criteria
Inclusion Criteria:
* Has competed a study of DS5141-A-J101
Exclusion Criteria:
* Significant safety issues in a study of DS5141-A-J101
* Patient who does not consent to use appropriate contraception
* Patient not appropriate to participant in the study as determined by the Investigator
Source: ClinicalTrials.gov (NCT04433234). StuddyBuddy aggregates publicly available trial information.
